|
Second primary malignancy (SPM) in patients (pts) with multiple myeloma (MM) receiving chimeric antigen receptor T-cell (CAR T) therapy or other systemic anticancer therapy (SACT): A comparative study using a real-world database. |
| |
|
Consulting or Advisory Role - GlaxoSmithKline; Janssen Oncology |
Research Funding - BMS (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Regeneron (Inst) |
Patents, Royalties, Other Intellectual Property - Novel bone anabolic agent in the treatment of cancer bone metastasis (Inst) |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
No Relationships to Disclose |
| |
|
Employment - Regeneron; Virginia Mason Medical Center (I) |
Stock and Other Ownership Interests - Regeneron |
| |
|
|
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
Research Funding - Regeneron |
Travel, Accommodations, Expenses - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
Stock and Other Ownership Interests - Bristol-Myers Squibb; Lilly; Pfizer; Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron; Sanofi |
Travel, Accommodations, Expenses - Regeneron |
| |
|
Employment - Cellectis, Inc; Regeneron |
Stock and Other Ownership Interests - Cellectis, Inc; Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |
Research Funding - Regeneron |
Travel, Accommodations, Expenses - Regeneron |
| |
|
|
Stock and Other Ownership Interests - Regeneron |